Bortezomib - NDC Database
35 records found
Page:
0143-9098 Jul 27, 2022
Bortezomib 3.5 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Hikma Pharmaceuticals USA Inc.
Bortezomib 3.5 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Hikma Pharmaceuticals USA Inc.
0409-1700 Jul 27, 2022
Bortezomib 3.5 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Hospira, Inc.
Bortezomib 3.5 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Hospira, Inc.
0409-1703 May 16, 2022
Bortezomib 2.5 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Hospira, Inc.
Bortezomib 2.5 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Hospira, Inc.
0409-1704 May 16, 2022
Bortezomib 1 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Hospira, Inc.
Bortezomib 1 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Hospira, Inc.
0781-3258 May 31, 2022
Bortezomib 3.5 mg Intravenous Injection, Powder, Lyophilized, for Solution by Sandoz Inc
Bortezomib 3.5 mg Intravenous Injection, Powder, Lyophilized, for Solution by Sandoz Inc
10019-991 May 02, 2022
Bortezomib 3.5 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Baxter Healthcare Corporation
Bortezomib 3.5 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Baxter Healthcare Corporation
25021-244 May 01, 2022
Bortezomib 3.5 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Sagent Pharmaceuticals
Bortezomib 3.5 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Sagent Pharmaceuticals
31722-303 May 03, 2024
Bortezomib 3.5 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Camber Pharmaceuticals, Inc.
Bortezomib 3.5 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Camber Pharmaceuticals, Inc.
43598-426 Jul 26, 2022
Bortezomib 3.5 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Dr.reddy's Laboratories, Inc.
Bortezomib 3.5 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Dr.reddy's Laboratories, Inc.
43598-865 Nov 01, 2019
Bortezomib 3.5 mg Intravenous Injection, Powder, Lyophilized, for Solution by Dr.reddy's Laboratories Inc
Bortezomib 3.5 mg Intravenous Injection, Powder, Lyophilized, for Solution by Dr.reddy's Laboratories Inc
50742-484 May 01, 2022
Bortezomib 3.5 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Ingenus Pharmaceuticals, LLC
Bortezomib 3.5 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Ingenus Pharmaceuticals, LLC
51817-586 May 02, 2022
Bortezomib 3.5 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Pharmascience Inc.
Bortezomib 3.5 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Pharmascience Inc.
55150-337 May 02, 2022
Bortezomib 3.5 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Auromedics Pharma LLC
Bortezomib 3.5 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Auromedics Pharma LLC
60505-6050 May 02, 2022
Bortezomib 3.5 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Apotex Corp
Bortezomib 3.5 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Apotex Corp
63323-721 Nov 06, 2017
Bortezomib 1 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Fresenius Kabi USA, LLC
Bortezomib 1 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Fresenius Kabi USA, LLC
63323-821 May 02, 2022
Bortezomib 3.5 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Fresenius Kabi USA, LLC
Bortezomib 3.5 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Fresenius Kabi USA, LLC
63759-3032 Sep 25, 2024
Bortezomib 3.5 mg/1.4ml Intravenous; Subcutaneous Injection by Shilpa Medicare Limited
Bortezomib 3.5 mg/1.4ml Intravenous; Subcutaneous Injection by Shilpa Medicare Limited
67184-0530 May 02, 2022
Bortezomib 3.5 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Qilu Pharmaceutical Co., Ltd.
Bortezomib 3.5 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Qilu Pharmaceutical Co., Ltd.
Page:
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.